serw-MX  [xml]  
 


    
 DeCS Categories

B01 Eukaryota .
B01.650 Plants .
B01.650.940 Viridiplantae .
B01.650.940.800 Streptophyta .
B01.650.940.800.575 Embryophyta .
B01.650.940.800.575.912 Tracheophyta .
B01.650.940.800.575.912.250 Magnoliopsida .
B01.650.940.800.575.912.250.198 Caryophyllanae .
B01.650.940.800.575.912.250.198.500 Caryophyllales .
B01.650.940.800.575.912.250.198.500.675 Molluginaceae .
C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.465 Neoplasms, Germ Cell and Embryonal .
C04.557.465.625 Neuroectodermal Tumors .
C04.557.465.625.600 Neoplasms, Neuroepithelial .
C04.557.465.625.600.380 Glioma .
C04.557.470 Neoplasms, Glandular and Epithelial .
C04.557.470.670 Neoplasms, Neuroepithelial .
C04.557.470.670.380 Glioma .
C04.557.580 Neoplasms, Nerve Tissue .
C04.557.580.625 Neuroectodermal Tumors .
C04.557.580.625.600 Neoplasms, Neuroepithelial .
C04.557.580.625.600.380 Glioma .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.369 Gliosis .
D02 Organic Chemicals .
D02.065 Amides .
D02.065.277 Benzamides .
D02.065.277.456 Imatinib Mesylate .
D02.078 Amidines .
D02.078.370 Guanidines .
D02.078.370.141 Biguanides .
D02.078.370.141.075 Buformin .
D02.241 Carboxylic Acids .
D02.241.223 Acids, Carbocyclic .
D02.241.223.100 Benzoates .
D02.241.223.100.100 Benzamides .
D02.241.223.100.100.435 Imatinib Mesylate .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.127 Benzoates .
D02.455.426.559.389.127.085 Benzamides .
D02.455.426.559.389.127.085.465 Imatinib Mesylate .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.606 Piperazines .
D03.383.606.405 Imatinib Mesylate .
D03.383.742 Pyrimidines .
D03.383.742.349 Imatinib Mesylate .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.317 Gastrointestinal Hormones .
D06.472.317.469 Proglucagon .
D06.472.317.469.249 Glicentin .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.765 Plant Proteins .
D12.776.765.725 Seed Storage Proteins .
D12.776.765.725.500 Prolamins .
D12.776.765.725.500.500 Glutens .
D12.776.765.725.500.500.400 Gliadin .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.389.745.335 Dipeptidyl-Peptidase IV Inhibitors .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.422 Hypoglycemic Agents .
D27.505.696.422.500 Dipeptidyl-Peptidase IV Inhibitors .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Imatinib Mesylate .
Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide .
CGP 57148 .
CGP-57148 .
CGP57148B .
Gleevec .
Glivec .
Imatinib .
Imatinib Methanesulfonate .
ST 1571 .
ST1571 .
STI 571 .
STI-571 .
STI571 .
CGP57148 .
Mesylate, Imatinib .
Methanesulfonate, Imatinib .
A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. .
1.00
339063
 
Molluginaceae .
Mollugos .
Glinus .
Mollugo .
A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Some members contain triterpenoid saponins. .
0.64
029
 
Glioma .
Malignant Glioma .
Mixed Glioma .
Glial Cell Tumor .
Glioma, Malignant .
Glioma, Mixed .
Gliomas .
Gliomas, Malignant .
Gliomas, Mixed .
Malignant Gliomas .
Mixed Gliomas .
Tumor, Glial Cell .
Tumors, Glial Cell .
Glial Cell Tumors .
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) .
0.63
27532903
 
Gliosis .
Glioses .
Astrocytosis .
The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion. .
0.61
244007
 
Dipeptidyl-Peptidase IV Inhibitors .
Dipeptidyl-Peptidase 4 Inhibitors .
Dipeptidyl Peptidase 4 Inhibitors .
Dipeptidyl Peptidase IV Inhibitors .
Inhibitors, Dipeptidyl-Peptidase IV .
Gliptins .
Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. .
0.59
142851
 
Gliadin .
alpha-Gliadin .
alpha Gliadin .
Simple protein, one of the prolamines, derived from the gluten of wheat, rye, etc. May be separated into 4 discrete electrophoretic fractions. It is the toxic factor associated with CELIAC DISEASE. .
0.59
372535
 
Glicentin .
Glicentine .
Proglucagon (1-69) .
A 69-amino acid peptide derived from the N-terminal of PROGLUCAGON. It is mainly produced by the INTESTINAL L CELLS. Further processing of glicentin yield a 30-amino acid N-terminal peptide (glicentin-related polypeptide) and a 37-amino acid peptide OXYNTOMODULIN. Both glicentin and oxyntomodulin can reduce digestive secretions and delay gastric emptying. .
0.59
 
Buformin .
1-Butylbiguanide .
Adebit .
Gliporal .
Silubin .
Silubin Retard .
1 Butylbiguanide .
Retard, Silubin .
Butylbiguanide .
An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation. .
0.58
3139